Eros MD's medically guided weight loss programs combine GLP-1 and GIP weight loss medications with physician oversight, metabolic assessment, and a plan built around your body. Not a fad. Not a supplement. Real medicine.
why GLP-1
GLP-1 and GIP receptor agonists represent the most clinically significant advance in weight loss medicine in decades. Unlike older approaches that relied on stimulants or willpower-based programs, these medications work through the body's own metabolic and appetite regulation systems.
They mimic naturally occurring hormones that regulate hunger, satiety, and blood sugar. The result is a physiological reduction in appetite, not a behavioral fight against cravings. Modern clinical trials have demonstrated average weight loss of 15 to 22 percent of body weight, previously achievable only through bariatric surgery.
Eros MD makes physician-supervised weight loss medication programs accessible online at transparent pricing, with the medical oversight these powerful medications require. The specific medication and dose are clinical decisions made by your provider.
treatment options
Every treatment plan is built by licensed physicians who look at the root cause, not just the symptom. The medication and dose are determined by your provider during evaluation.
GLP-1 receptor agonists are the most widely studied class of weight loss medications. Clinical trials show average weight reduction of approximately 15 percent of body weight. Weekly injection. Provider-determined dosing and titration.
~15 percent average body weight reduction in trials
The newest generation of weight loss medication activates both GLP-1 and GIP receptors. Clinical trials show average weight reduction of up to 22 percent of body weight, the most effective pharmaceutical option currently available.
Up to ~22 percent average body weight reduction in trials
Not sure how these medications work? Our overview explains the mechanism, what to expect, and how providers determine the right fit for you.
GLP-1 / GIP medications are effective for both men and women, but hormonal factors and metabolic differences matter. Eros MD's women's program accounts for the full picture.
medication comparison
GLP-1 Receptor Agonist
Dual GLP-1 / GIP Agonist
Feature
Mechanism
Avg Weight Loss
Administration
Best For
GLP-1 Receptor Agonist
GLP-1 only
~15 percent
Weekly injection
First-line, longest track record
Dual GLP-1 / GIP Agonist
GLP-1 + GIP
Up to ~22 percent
Weekly injection
Maximum efficacy, newer generation
why oversight matters
Weight loss medications are powerful, and that is precisely why physician oversight is not optional. Dosing titration, side effect management, contraindication screening, and ongoing monitoring are the difference between a safe, effective program and a potentially harmful one.
Eros MD's weight loss program includes comprehensive metabolic and health assessment, physician-determined dosing protocol, ongoing monitoring and check-ins, side effect management support, and a provider who adjusts your plan as your body responds.
Every program begins with a provider evaluation, not a questionnaire that auto-approves everyone.
Regular check-ins, dose adjustments, and monitoring throughout.
Weight loss medication works best alongside physician guidance on nutrition, activity, and metabolic health.
Questions worth asking
GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonists are medications that mimic naturally occurring gut hormones involved in appetite regulation, satiety, and blood sugar control. They reduce hunger physiologically, not through stimulant effects. Specific medications and dosing are determined by your physician.
Clinical trials of GLP-1 receptor agonists show average weight loss of approximately 15 percent of body weight, and dual GLP-1/GIP agonists show up to 22 percent over approximately 68 to 72 weeks. Individual results vary based on starting weight, adherence, diet, activity, and metabolic factors. Your provider sets realistic expectations during evaluation.
Yes. GLP-1 and GIP weight loss medications are prescription-only. Eros MD provides physician evaluation online. If you qualify medically, your provider will determine the appropriate medication and issue a prescription dispensed from a licensed pharmacy.
Most patients regain a significant portion of lost weight after stopping these medications. Long-term management planning, including whether to continue, taper, or transition, should be planned with your Eros MD physician.
Coverage varies significantly. Many plans cover these medications for Type 2 diabetes but not always for weight management. Eros MD provides transparent pricing and can help you understand your options.
learn more
Physician-written guidance on GLP-1 medications, treatment selection, and what to expect from a medically guided approach. From mechanism to long-term management.
A step-by-step look at how GLP-1 medications work, what the first few weeks feel like, and how your body adapts over time.
Compare effectiveness, mechanism, and key considerations to help determine which class of weight loss medication may be a better fit for your goals.
Understand how medical oversight improves safety, results, and long-term success compared to unsupervised approaches.
A clear breakdown of how GLP-1 medications work with your body's natural systems to regulate hunger and metabolism.